Home / Archive / JST Vol. 27 (4) Oct. 2019 / JST-1644-2019

 

Identifying Analogues Of 2-Deoxyglucose, Alpha-D-Glucose and Beta-D-Glucose-6-Phosphate as Potential Inhibitors of Human Hexokinase II for the Development of Anti-Dengue Therapeutics

Suriyea Tanbin, Nurhainis Ogu Salim and Fazia Adyani Ahmad Fuad

Pertanika Journal of Science & Technology, Volume 27, Issue 4, October 2019

Published: 21 October 2019

The human hexokinase isoform II (HKII) is one of the important enzymes for dengue virus (DENV) replication and thus has been suggested as a potential therapeutic target for DENV drug development. In this work, compounds were identified using Ultrafast Shape Recognition with CREDO Atom Types (USRCAT) by utilizing both HKII’s substrate and product; alpha-D-glucose (GLC) and beta-D-glucose-6-phosphate (BG6), as well as a known HKII’s inhibitor, 2-deoxyglucose (2DG), as the query molecules. The analogues of the three query molecules were subsequently docked against the HKII’s crystal structure (PDB ID: 2NZT) by using Auto Dock 4 program on Chain B, where the active sites and strong bonds were located. Among the top-ranked compounds, Compound 4 (ZINC26898487), which was the most similar to 2DG, showed the best binding energy (-7.63 kcal/mol) and contained two H bonds. Compound 9 (ZINC16930948), an analogue of GLC emerged as the best inhibitor candidate because it had six H bonds. Similarly, among the molecules similar to BG6, Compound 14 (ZINC4403351) had been suggested as a potential inhibitor because it contained four strong H bonds. All compounds were predicted to be non-toxic, based on Toxicity Estimation Software Tool (TEST) analysis. By providing these valuable findings, this study has paved the way for the discovery of compounds that should be further tested for the development of anti-dengue drugs.

ISSN 0128-7702

e-ISSN 2231-8534

Article ID

JST-1644-2019

Download Full Article PDF

Share this article

Related Articles